Califf: FDA will be a ‘more activist’ agency

Regulatory NewsRegulatory NewsAPIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsMedical DevicesNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/Policy